NORML

MARCH 14, 2019

1647 , the Veterans Equal Access Act, which expands medical cannabis access to eligible military veterans. Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. Presently, V.A.

Access 207

Access Chronic Pain Treatment Conditions 207

Cannabis Law Report

MAY 19, 2022

When Thomas Hartle indulges in a session of psilocybin treatment, the end-of-life anxiety, distractions and noises associated with his terminal colon cancer go away. “Before the treatment, it’s like you’re sitting in your car. There must have been a lot of treatments done beforehand so the application is solid.”

Therapy 52

Therapy Patients Treatment Clinical Trials 52

MMJ Recs

MARCH 28, 2024

Navigating the world of medical marijuana (MMJ) in Iowa can be a daunting task for patients seeking alternative treatments. From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey.

Patients 52

Patients Treatment Research and Development Therapy 52

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 122

Treatment Cannabinoids Blood Pressure THC 122

The Cannigma

AUGUST 5, 2022

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Veriheal

JUNE 29, 2021

In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. The FDA refers to this program as the expanded access program on their website. A Push by Patients. Patients Are Not In This Alone.

Therapy 55

Therapy DEA Patients Clinical Trials 55

NORML

NOVEMBER 8, 2019

This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy.

Access 200

Access Marijuana Treatment Legislation 200

Veriheal

MARCH 23, 2022

Bronner’s expressed gratitude and excitement for its new partnership with healthcare organization Enthea to expand its employee medical benefits to include psychedelic therapies. Enthea is expected to expand its psychedelic treatment options to include other substances, such as psilocybin and MDMA , pending FDA approval.

Therapy 95

Therapy Treatment Supply Chain Pharmaceutical 95

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

OCTOBER 4, 2021

Advanced Illness , Oregon Psilocybin Advisory Board , Oregon Psilocybin Services Act , Psilocybin , Psilocybin Therapy , Psychedelics , Right To Try. One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression.

Therapy 52

Therapy Patients Law Clinical Trials 52

NORML

FEBRUARY 13, 2019

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.

Legislation 230

Legislation Access Chronic Pain Marijuana 230

Cannabis Law Report

JANUARY 6, 2022

CNSX : FTRP; OTCMKTS : FTRPF), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canada’s Special Access Program (SAP). Field Trip Health Ltd.

Access 52

Access Patients Therapy Conditions 52

Cannabis Law Report

MARCH 22, 2023

When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures equitable patient access, say experts.

Therapy 52

Therapy Treatment Conditions Access 52

Cannabis Law Report

JULY 13, 2022

Physicians and researchers are urging New Mexico legislators to allow the use of psychedelic mushrooms in mental health therapy aimed at overcoming depression, anxiety, psychological trauma and alcoholism. Oregon is so far the only state to legalize the therapeutic use of psilocybin.

Therapy 52

Therapy Legislation Access Decriminalization 52

Cannabis Law Report

JANUARY 6, 2022

This blog post will explain how psilocybin patenting and other factors could make Oregon’s psilocybin program prohibitively expensive for low-income patients, and how big pharma is maneuvering to monopolize psychedelic therapy. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

MMJ Recs

OCTOBER 9, 2023

Pain management in Texas has evolved significantly in recent years with the emergence of MMJ as a viable treatment option. As Texas residents seek alternative therapies for chronic pain and other debilitating conditions, it becomes crucial to navigate the world of MMJ pain management centers effectively.

Chronic Pain 52

Chronic Pain Patients Treatment Conditions 52

Veriheal

JUNE 21, 2023

There will also be measures put in place to control therapeutic access to psilocybin while awaiting federal reform. If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments.

Access 97

Access Legalization Research and Development Legislation 97

MMJ Recs

APRIL 5, 2024

With cancer care, New York has emerged as a beacon of progress, offering patients access to a holistic approach that includes medical marijuana. With its therapeutic benefits increasingly recognized, medical cannabis has become an integral component of cancer treatment plans in the state.

Treatment 52

Treatment Marijuana Patients Therapy 52

MMJ Recs

JANUARY 16, 2023

West Virginia pain treatment is very effective at treating a range of chronic pain conditions. Pain management doctors in West Virginia use a variety of treatments, including medical marijuana , to treat chronic pain. Read on to discover some of the best pain management centers in West Virginia that MMJ patients should know about.

Chronic Pain 98

Chronic Pain Patients Treatment Medicine 98

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has the potential to reduce opioid dependence and addiction, leading to safer and healthier communities.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

APRIL 4, 2022

Congress, signed into law by President Trump, with 41 state enactments, give terminally ill patients access to experimental medicines still in development? But the Drug Enforcement Agency is barring access to one such experimental medicine: psilocybin, also known in its fungal form as “magic mushrooms.”. Read more at.

Access 52

Access Patients DEA Research and Development 52

Veriheal

JUNE 17, 2022

Cannabis has been shown to effectively block pain, and recent research confirms that it reduces the need for opiate pain killers among cancer patients. These patients arguably have the most to gain from cannabis, as it can significantly improve a host of their symptoms and could even contribute to killing cancer cells. .

Patients 98

Patients Treatment Pharmaceutical Consumption 98

Veriheal

JUNE 7, 2021

Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Therapy 82

Therapy Treatment Conditions Clinical Trials 82

Cannabis Law Report

JUNE 9, 2022

Decriminalisation in the ACT but still illegal to do TGA-approved psychedelic therapy. The substances in clinical settings are unadulterated, the dosing levels are controlled, patients can’t take the substances home and patients are screened to ensure that they have no contraindications. Here’s what they say.

Therapy 52

Therapy Medicine Recreational Decriminalization 52

MMJ Recs

FEBRUARY 27, 2024

As the state continues to navigate the complexities of legalization, patients, dispensaries, and the cannabis industry are witnessing significant changes. Dispensaries serve as the primary access point for patients seeking medical marijuana products. The severity and progression of symptoms can vary from person to person.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

United Patients Group

NOVEMBER 21, 2023

Traditional treatments with prescription medications can sometimes be insufficient or accompanied by undesirable side effects, leaving patients in search of alternative methods for pain relief. Harlequin is ideal for patients seeking clear-headed pain relief during daytime hours.

Chronic Pain 82

Chronic Pain Strains Patients Marijuana 82

MMJ Recs

SEPTEMBER 19, 2023

In this article, we’ll explore the various chronic pain treatment options in Missouri, highlight top-rated pain specialists in the state, and delve into some of the specific services available, such as non-surgical pain relief in Missouri. Finding effective treatment is crucial to improving your quality of life.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

Canna Law Blog

NOVEMBER 10, 2020

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments. It’s quite restrictive.

Therapy 78

Therapy Clinical Trials Decriminalization Patients 78

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. About Curaleaf International.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Veriheal

MAY 26, 2022

Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

AUGUST 21, 2023

Implications of Cohen’s Donation on Psychedelic Studies MAPS intends to submit an MDMA drug application to FDA this year to be approved for mental health treatment. If the FDA approves the application, it will pave the way for integrating psychedelic treatment into mainstream medical health care.

Therapy 90

Therapy Research and Development Treatment Environment 90

Cannabis Law Report

MAY 4, 2022

Connecticut lawmakers sent the governor a large-scale budget bill on Tuesday that includes provisions to set the state up to provide certain patients with access to psychedelic-assisted treatment using substances like MDMA and psilocybin.

Treatment 52

Treatment Programs Therapy Access 52

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, Partners with Pioneering Health Plan Administrator, Enthea, to Provide Psychedelic Therapy as Employee Healthcare Benefit. Leading US Company to Offer Employee Coverage for Ketamine Assisted Therapy to Promote Mental Health. First Ever Partnership Between Health Plan Administrator and.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

Cannabis Law Report

OCTOBER 22, 2021

(TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce that following discussions with the U.K. The ILAP accelerates time to market and facilitates patient access to emerging and novel treatments. About Small Pharma.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52